Abstract:The incidence of primary poorly differentiated neuroendocrine carcinoma (PDNC) of the hypopharynx iŝ4%. However, the disease pathogenesis, natural history, and prognostic factors remain poorly understood. We report the case of a 66-year-old man who presented with multiple metastases from primary PDNC of the hypopharynx. Physical examination revealed ã3×4 cm left cervical mass located at the level III, with tenderness and an unclear boundary. Laryngoscopy revealed a large mass arising from the posterior hypopha… Show more
“…The symptoms include neck mass and dysphagia; specifically, the most common is s globus sensation. Other symptoms are weight loss, dyspnea, hoarseness, and throat pain [2]. With laryngeal lesions, it is possible to have respiratory discomfort.…”
Section: Discussionmentioning
confidence: 99%
“…Small-Cell NEC (SCNEC) usually comes from the pulmonary tract, but it rarely also arises from genitourinary, gastrointestinal, breast, neck, also head areas. It mainly occurs in the larynx, salivary gland, nose, and paranasal sinuses [2]. The oral cavity accounts for 9 percent, the oropharynx for 12 percent, the larynx for 35 percent, the hypopharynx for 4 percent, the nasopharynx for 10 percent, and approximately 30% of the total is comprised of the sinonasal [3].…”
Neuroendocrine carcinoma (NEC) is a type of malignancy that affects the nerve and endocrine systems and secrete neuropeptides into the bloodstream. Because there are significant treatment differences between primary NEC of the head and neck and typical squamous cell carcinoma, it is critical to distinguish between the two types of cancer. Primary NEC of the head and neck is rare cancer that should be distinguished from typical squamous cell carcinoma. Therefore, this study aimed to present the characteristic of head and neck neuroendocrine carcinomas at Hasan Sadikin General Hospital Bandung for 2016 to 2020. This is a descriptive retrospective study with head and necks neuroendocrine tumor patients at Hasan Sadikin General Hospital Bandung from 2016 to 2020. Demographic, clinical, and histopathological characteristics were obtained through the medical record data of patients. Samples were taken through consecutive sampling methods. This is a descriptive retrospective study with head and necks neuroendocrine tumor patients at Hasan Sadikin General Hospital Bandung from 2016 to 2020. Demographic, clinical, and histopathological characteristics were obtained through the medical record data of patients. Samples were taken through consecutive sampling methods. Head and neck neuroendocrine carcinomas have distinct characteristics and histopathological entities. Positive immunohistochemistry assay was significant findings to establish the diagnosis
“…The symptoms include neck mass and dysphagia; specifically, the most common is s globus sensation. Other symptoms are weight loss, dyspnea, hoarseness, and throat pain [2]. With laryngeal lesions, it is possible to have respiratory discomfort.…”
Section: Discussionmentioning
confidence: 99%
“…Small-Cell NEC (SCNEC) usually comes from the pulmonary tract, but it rarely also arises from genitourinary, gastrointestinal, breast, neck, also head areas. It mainly occurs in the larynx, salivary gland, nose, and paranasal sinuses [2]. The oral cavity accounts for 9 percent, the oropharynx for 12 percent, the larynx for 35 percent, the hypopharynx for 4 percent, the nasopharynx for 10 percent, and approximately 30% of the total is comprised of the sinonasal [3].…”
Neuroendocrine carcinoma (NEC) is a type of malignancy that affects the nerve and endocrine systems and secrete neuropeptides into the bloodstream. Because there are significant treatment differences between primary NEC of the head and neck and typical squamous cell carcinoma, it is critical to distinguish between the two types of cancer. Primary NEC of the head and neck is rare cancer that should be distinguished from typical squamous cell carcinoma. Therefore, this study aimed to present the characteristic of head and neck neuroendocrine carcinomas at Hasan Sadikin General Hospital Bandung for 2016 to 2020. This is a descriptive retrospective study with head and necks neuroendocrine tumor patients at Hasan Sadikin General Hospital Bandung from 2016 to 2020. Demographic, clinical, and histopathological characteristics were obtained through the medical record data of patients. Samples were taken through consecutive sampling methods. This is a descriptive retrospective study with head and necks neuroendocrine tumor patients at Hasan Sadikin General Hospital Bandung from 2016 to 2020. Demographic, clinical, and histopathological characteristics were obtained through the medical record data of patients. Samples were taken through consecutive sampling methods. Head and neck neuroendocrine carcinomas have distinct characteristics and histopathological entities. Positive immunohistochemistry assay was significant findings to establish the diagnosis
Background
Primary neuroendocrine carcinomas (NECs) are very rare entities accounting for 0.49% of all malignancies. Within the head and neck, the most common sites are the larynx and paranasal sinuses, while the hypopharynx is seldom described.
Case
We present a patient with a poorly differentiated metastatic NEC of the hypopharynx treated palliatively with organ‐preserving surgery and post‐operative chemotherapy, and literature review for well‐documented pure hypopharyngeal NECs. Our patient died of chest infection during chemotherapy, 4 months after surgery.
Conclusion
Chemotherapy remains the mainstay of treatment in the presence of metastases with 2‐year overall survival of 15.7%. Due to the aggressive nature of poorly differentiated metastatic NECs, surgical management is seldom considered. We report and advocate the successful palliative role of organ‐preserving, minimally invasive trans‐oral LASER micro‐surgery and neck dissection to control loco‐regional head and neck disease, safe‐guarding better quality of home life, despite limited life expectancy for this condition.
“…Similar to most malignant tumors, the physiological environment of ACC is characterized by local hypoxia that results from an insu cient oxygen supply [5][6][7][8]. Under hypoxic conditions, cancer cells undergo metabolic adaptation through the Warburg effect, which involves glycolysis and a signi cant increase in glucose uptake [9][10][11][12][13]. Glucose transporter-1 (GLUT1) is important for glucose uptake and transportation in cancer cells [11][12][13][14].…”
Background
Multiple studies have demonstrated a strong association between glucose transporter-1 (GLUT1) and the development and recurrence of adenoid cystic carcinoma (ACC). Here, we investigate the effect of GLUT1 knockdown in adenoid cystic carcinoma.
Methods
The effect of hypoxic on progression and autophagy of SACC83 and SACC-LM cell lines was examined by flow cytometry, Transwell assay and fluorescence microscopy. GLUT1 expression was inhibited by using siRNA. ACC tumor-bearing model mice were treated with lentivirus delivering either GLUT1 shRNA or an autophagy inhibitor (chloroquine).
Results
Hypoxic conditions increased progression and autophagy of SACC83 and SACC-LM cell lines. The hypoxic effect was attenuated upon GLUT1 knockdown. In vivo, lentivirus delivering GLUT1 shRNA combined with CQ had the greatest inhibitory effect on tumor volume, weight, Ki67 expression and autophagy in tumor tissues.
Conclusions
Hypoxia can promote ACC progression by upregulating GLUT1 expression. Inhibition of GLUT1 expression and autophagy led to the suppression of ACC cell proliferation both in vitro and in vivo.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.